STAT - Reporting from the frontiers of health and medicine

Politics

Health

In the Lab

By Lauren Aguirre

Pharmalot Was it really a smart move for the FDA to approve a ‘smart pill’ for treating schizophrenia?
First Opinion I wanted to try medical marijuana. Why couldn’t my doctors help me?
Politics Tracking Washington’s moves on drug pricing
First Opinion A bird’s-eye view of clinical trials provides new perspectives on drug research and development
First Opinion Economic barriers to organ transplants from living donors must be removed

Exclusive analysis of biotech, pharma, and the life sciences

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Special Report

Heavyweights

Biotech

Biotech

Health

Health

Health What the Ebola emergency means, what it doesn’t mean, and what’s next
Special Report How pharma, under attack from all sides, keeps winning in Washington
First Opinion A bird’s-eye view of clinical trials provides new perspectives on drug research and development
First Opinion I wanted to try medical marijuana. Why couldn’t my doctors help me?
In the Lab Role of seizures in Alzheimer’s disease is gaining overdue attention